For research use only. Not for therapeutic Use.
S-HP210(Cat No.:I043549)is a small molecule inhibitor that targets the protein kinase B (AKT), a key regulator of cell survival, growth, and metabolism. AKT is often dysregulated in cancer, leading to tumor growth, metastasis, and resistance to therapy. By selectively inhibiting AKT, S-HP210 aims to block these oncogenic signaling pathways, suppress tumor progression, and enhance the effectiveness of existing cancer treatments. This compound is being studied for its potential in treating various cancers, particularly those driven by AKT activation, offering a targeted approach to cancer therapy by disrupting key survival pathways.
Synonyms | 4-[(4-oxo-2-sulfanylidene-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-[(1S)-1-phenylethyl]benzamide |
Molecular Formula | C22H19N3O2S2 |
Purity | ≥95% |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |